Cargando…
免疫组化法检测NSCLC患者EGFR突变的相关研究
BACKGROUND AND OBJECTIVE: Patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR) respond well to EGFR-tyrosine kinase inhibitor therapy. Immunohistochemistry (IHC) is a simple and widely used technique in clinical pathology laboratories. I...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000282/ https://www.ncbi.nlm.nih.gov/pubmed/25936885 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.01 |